• D. Boral Capital Reiterates Buy Rating for ImmunityBio (NASDAQ:IBRX)

    Source: Buzz FX / 27 Jan 2025 12:00:19   America/New_York


    D. Boral Capital Reiterates Buy Rating for ImmunityBio (NASDAQ:IBRX) Written by MarketBeat January 27, 2025 Share Link copied to clipboard. ImmunityBio ( NASDAQ:IBRX - Get Free Report ) 's stock had its "buy" rating reiterated by stock anal
    Read more...
Share on,